NCT07014644View on ClinicalTrials.gov

A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

May 13, 2020

Study Completion Date

May 19, 2020

Conditions
Opioid Dependence
Interventions
DRUG

0.9g Naltrexone Implant + 0.6g Naltrexone Implant Placebo

0.9g Naltrexone Implant + 0.6g Naltrexone Implant Placebo

DRUG

1.5g Naltrexone Implant

1.5g Naltrexone Implant

Trial Locations (1)

410011

The Second Xiangya Hospital of Central South University Address: No. 139, Renmin Road Central, Changsha City, Changsha

All Listed Sponsors
lead

Shenzhen Sciencare Medical Industries Co., Ltd.

INDUSTRY

NCT07014644 - A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone | Biotech Hunter | Biotech Hunter